Baker Brothers Life Sciences Capital (GP), LLC Insider Trading $BCRX BIOCRYST PHARMACEUTICALS INC
Get free email notifications about insider trading for Baker Brothers Life Sciences Capital (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Brothers Life Sciences Capital (GP), LLC. Baker Brothers Life Sciences Capital (GP), LLC is 10% Owner in HERON THERAPEUTICS, INC. /DE/ ($HRTX) and 10% Owner in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INCYTE CORP ($INCY) and Director in NEUROGEN CORP ($NRGN) and 10% Owner in IDERA PHARMACEUTICALS, INC. ($IDRA) and 10% Owner in TAPESTRY PHARMACEUTICALS, INC ($NPRO) and 10% Owner in VIROPHARMA INC ($VPHM) and Director in SYNAGEVA BIOPHARMA CORP ($GEVA) and 10% Owner in ADOLOR CORP ($ADLR) and 10% Owner in ALLOS THERAPEUTICS INC ($ALTH) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN) and Director in GENOMIC HEALTH INC ($GHDX) and 10% Owner in AUXILIUM PHARMACEUTICALS INC ($AUXL).
Baker Brothers Life Sciences Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Brothers Life Sciences Capital (GP), LLC: 10% Owner
Holdings: 3,831,534 shares
Current Value: $21,724,798
Latest Transaction: Jun 01 2009
$BCRX Market Capitalization: $427.06M
$BCRX Previous Close: $5.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Brothers Life Sciences Capital (GP), LLC in BIOCRYST PHARMACEUTICALS INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADLR, ALTH, IBPI, AUXL, BCRX, GHDX, HRTX, IDRA, INCY, NRGN, SGEN, GEVA, NPRO, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 3.89 | 42,814 | 166,332 | 3,831,534 | 3.9 M to 3.8 M (-1.11 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 3.86 | 110,557 | 427,203 | 3,874,348 | 4 M to 3.9 M (-2.77 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.12 | 105,881 | 436,526 | 3,984,905 | 4.1 M to 4 M (-2.59 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.30 | 20,567 | 88,465 | 4,090,786 | 4.1 M to 4.1 M (-0.50 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.50 | 152,494 | 686,848 | 4,111,353 | 4.3 M to 4.1 M (-3.58 %) |
| Jun 01 2009 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Sell | S | 4.45 | 84,619 | 376,851 | 4,263,847 | 4.3 M to 4.3 M (-1.95 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 0.98 | 7,401 | 7,237 | 4,348,466 | 4.3 M to 4.3 M (+0.17 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 0.91 | 31,071 | 28,402 | 4,341,065 | 4.3 M to 4.3 M (+0.72 %) |
| Nov 24 2008 | BCRX | BIOCRYST PHARMACEU ... | Baker Brothers Life Sciences C ... | 10% Owner | Buy | P | 1.00 | 303,517 | 303,517 | 4,309,994 | 4 M to 4.3 M (+7.58 %) |
Page: 1